ライフサイエンスコーパス: disease marker

1 s disorder and could be useful as a biologic disease marker.

2 ing pregnancy complications an early chronic disease marker.

3 d even without LVH suggesting it is an early disease marker.

4 nterhemispheric connectivity appears to be a disease marker.

5 ies to GAD might be the causative agent or a disease marker.

6 ct on clinical outcomes based on impact on a disease marker.

7 not been possible due to lack of a specific disease marker.

8 and who exhibited lower levels of surrogate disease markers.

9 e progression and pathology, and identifying disease markers.

10 fy highly effective and robust network-based disease markers.

11 with microstructural changes in small vessel disease markers.

12 etection of SARS-CoV-2 and potentially other disease markers.

13 matory study) comprised imaging and clinical disease markers.

14 These changes were proposed as disease markers.

15 l processes, and they may serve as important disease markers.

16 OD2) to identify potential delirium risk and disease markers.

17 seminated, >/=4 sulci), and key small vessel disease markers.

18 the sensitive and quantitative detection of disease markers.

19 deposits, remain one of the least understood disease markers.

20 sensors have been proposed to detect various disease markers.

21 cals and for the clinical analysis of glycan disease markers.

22 se score (BDS) with subjective and objective disease markers.

23 sment of their clinical potential as cardiac disease markers.

24 IV-infected individuals, controlling for HIV disease markers.

25 ich source of biological information such as disease markers.

26 te disease mechanisms and identify surrogate disease markers.

27 sensitive detection of infectious agents and disease markers.

28 of genotypes in candidate genes as potential disease markers.

29 ation by real-time PCR as a minimal residual disease marker after transplant.

30 licing and identify increased mitophagy as a disease marker and a therapeutic vulnerability in SRSF2P

31 te that microvascular reactivity is an early disease marker and advocate establishing therapies that

32 ibutes to albuminuria and could be used as a disease marker and future therapeutic target in diabetic

33 Hyperosmolarity is believed to be the disease marker and thus measuring it provides useful inf

34 ion with prostate carcinogenesis can provide disease markers and clues relevant to disease etiology.

35 characterize the MS prodrome, identify early disease markers and develop standardized criteria that w

36 e be used for screening single molecules for disease markers and for monitoring individual molecular

37 s a platform for the identification of early disease markers and for the efficient testing of novel t

38 y, we correlated each PTP locus with genetic disease markers and identified 4 PTPs that map to known

39 lymphoblastic leukaemia are well established disease markers and indicators of outcomes.

40 tionary tool for ultrasensitive detection of disease markers and infectious agents.

41 airment on treatment, whereas cardiovascular disease markers and inflammatory markers are.

42 lls is inversely associated with HIV-related disease markers and linked with delayed disease progress

43 way for considering CRMPs as potential early disease markers and modulation of their activity as ther

44 itative microRNA detection, the discovery of disease markers and non-invasive early diagnosis of canc

45 f the Bcr-Abl fusion kinase highlights novel disease markers and potential drug-responsive biomarkers

46 from population genomics are identifying new disease markers and potential novel drug targets to bett

47 (m(5)C), have been identified as prognostic disease markers and potential therapeutic targets for li

48 We also consider the use of matrikines as disease markers and potential therapeutic targets in lun

49 fferentiation; they could be investigated as disease markers and potential therapeutic targets.

50 splice variants of these genes might provide disease markers and targets for novel therapeutics.

51 could lay the foundation for development of disease markers and therapeutic intervention.

52 ther study of this network could lead to new disease markers and therapeutic targets for patients wit

53 itis B is usually a sustained improvement in disease markers and, when cirrhosis is considered, patie

54 ovide insight into why these microbes act as disease markers, and it overlooks cases where disease ri

55 hips between traits of the fecal metagenome, disease markers, and risk exposures.

56 e independently related to other Alzheimer's disease markers, and to examine individuals who are disc

57 erous studies, and several other Alzheimer's disease markers are emerging in the literature.

58 ations are replicating a previously reported disease-marker association but with the risk allele reve

59 We model disease-marker association in a candidate region via a h

60 fine map genes, investigators often test for disease-marker association in chromosomal regions with e

61 Case-control disease-marker association studies are often used in the

62 n important issue in case-control studies of disease-marker association, even within populations cons

63 linkage in the marker region, even given no disease-marker association.

64 n presumed to cause many of the unreplicated disease-marker associations reported in the literature,

65 ) has enabled the detection of pathogens and disease markers at extremely low levels.

66 The ability to detect disease markers at the single molecule level promises th

67 MicroRNAs show promise as disease markers because of their cell type-specific expr

68 ng mutation carriers and may represent early disease markers before the onset of hypertrophy.

69 This technology is also used to detect disease markers beyond acylcarnitines and amino acids, a

70 3-nitrotyrosine formation may not only be a disease marker but may also be involved in the pathogene

71 ardiometabolic risk factors, and fatty liver disease markers, but not glycemia, only while the device

72 ication algorithm to identify discriminative disease markers by learning on bipartite graphs.

73 found no difference in the gut microbiome or disease markers by probiotic application or antibiotic r

74 Early detection of disease markers can provide higher diagnostic power and

75 t in the cytoplasmic domain of the Hodgkin's disease marker, CD30, and binds TRAF3 in vitro.

76 anies to provide information on exposure and disease markers, clinical trial design for safety and ef

77 se severity, assessed using MRI small vessel disease markers, cognition and future risk of all-cause

78 each individual based on patient preference, disease markers, consequences of relapse, safety, and co

79 ltrasensitive in vivo multiplexed tumour and disease marker detection.

80 For in-situ disease markers detection, point-of-care (POC) diagnosis

81 paper-based microfluidic aptasensors for POC disease markers diagnosis.

82 rough photoacoustic detection of circulating disease markers directly in the bloodstream with an unpr

83 e electronic biosensors capable of analyzing disease markers directly in unprocessed body fluids will

84 can be constructed using any genotype-based disease-marker disequilibrium measure and is asymptotica

85 This study identifies IL-3 as a predictive disease marker for SARS-CoV-2 infections and as a potent

86 ion in the clinic is in need of quantitative disease markers for diagnosis and, most importantly, pro

87 fibrosis, reduced gene expression of several disease markers for hypertrophy and extracellular matrix

88 iant PNPLA3 I148M may complement other liver disease markers for NAFLD surveillance.

89 rated greatest resemblance and identified AD disease marker genes altered by T(H)2 + IL-22 such as do

90 using a low-density microarray containing 80 disease marker genes.

91 at followed, other cytogenetic and molecular disease markers have been described and effectively inco

92 s, but relationships with plasma Alzheimer's disease markers have not been investigated.

93 We examined two proteins used as disease markers, human C-reactive protein (CRP) and huma

94 significantly improved in two patients, and disease markers improved or stabilized in three patients

95 be considered when using the neoepitope as a disease marker in arthritis.

96 We obtained disease markers in 62 patients with VCI that included ne

97 er than whole bile, for developing miR-based disease markers in bile.

98 Protein analysis of potential disease markers in blood is complicated by the fact that

99 ulfonic acid, resulted in minimal changes in disease markers in BXSB mice.

100 ications including the analysis of candidate disease markers in complex mixtures such as serum.

101 od for the analysis of carbonyls to identify disease markers in exhaled breath.

102 rinalysis strips, used to detect an array of disease markers in humans, were tested on the lab stress

103 lammatory receptor expression or function as disease markers in patients with heart failure.

104 oth physiological parameters and biochemical disease markers in real time.

105 in suppressing viral activity and improving disease markers in short-term studies.

106 relationship between GBV-C infection and HIV disease markers in the context of highly active antiretr

107 Our results support including kidney disease markers in the identification of persons at high

108 will enable real-time optical assessment of disease markers in the living body.

109 can improve both biochemical and functional disease markers in the MSD mouse.

110 of HML-2 expression was not related to HIV-1 disease markers in this patient cohort.

111 ependent Galectin-1 binding induced a set of disease markers, including matrix metalloproteinases and

112 millions of cases of unhealthy behaviors and disease markers, including more than 22 million cases of

113 We examined relationships of liver disease markers, including patatin-like phospholipase do

114 (adenosine, 18 microM detection limit), to a disease marker (interferon-gamma of tuberculosis, 2.6 nM

115 Chronic abdominal pain without a biological disease marker is similar to irritable bowel syndrome, i

116 hubs as regulatory centers for oncogenes and disease markers, linking them to biological processes li

117 The lack of a recognizable disease marker makes this condition difficult to identif

118 the presence of PHOMSs reflects a secondary disease marker of unknown significance.

119 and perhaps even the gut, may correlate with disease markers of atherosclerosis.

120 on from latent infection to active pulmonary disease, markers of drug response and predictors of rela

121 ncluding amyloid, tau, cerebral small vessel disease markers on MRI, and vascular risk factors.

122 ctures towards ultrasensitive biosensing for disease markers or pathogens is of high importance.

123 ciations between heavy marijuana use and HIV disease markers or white blood cell (WBC) count were exa

124 No significant change in plasma metabolic disease markers over the study period was observed, but

125 and therefore amenable to the development of disease marker panels.

126 sults in observation of previously invisible disease marker-positive cell populations in human glioma

127 ed to calculate the functional small-airways disease marker PRM(fSAD) and Hounsfield unit (HU)-based

128 we demonstrate the quantitative analysis of disease-marker proteins by continuously separating the a

129 binding sites in LMP1 and the CD30 Hodgkin's disease marker provides further evidence that a TRAF3-me

130 rovide a fast and systematic way to identify disease markers relevant to clinical care.

131 interval: BM disease resolved and all other disease markers significantly improved in two patients,

132 metabolic dysfunction-associated fatty liver disease markers, such as collagen and lipids, which are

133 HIV disease markers, such as viral load and CD4 cell counts,

134 1 (p-tau181) is a well-validated Alzheimer's disease marker that could potentially seed progressive n

135 are dependent on the qualification of these disease markers that are intended to be substitutes for

136 re, it is vital to develop novel noninvasive disease markers that can effectively phenotype, facilita

137 e used as molecular imaging probes to target disease markers, thereby extending applications of MRI.

138 uture prospects, ranging from the search for disease markers to challenging developments such as stem

139 rge community sample, the addition of kidney disease markers to conventional risk factors improved pr

140 isease course and severity better than other disease markers to date.

141 ys to produce new behaviors, thereby linking disease markers to noninvasive sensing and reprogrammed

142 Label-free nanosensors can detect disease markers to provide point-of-care diagnosis that

143 between indoor incense burning and vascular disease markers upon cognitive functions.

144 Finding early disease markers using non-invasive and widely available

145 fications, additional testing for infectious disease markers, viral inactivation processes, and refin

146 high potential of FERS for the detection of disease markers was demonstrated with the analysis of 27

147 al agents, possible contributing factors, or disease markers-well demonstrated in animal models-remai

148 Disease markers were detected using nanoparticles to pro

149 stically significant associations with these disease markers were found for the CBD cases with the DD

150 Counterintuitively, disease markers were more pronounced in Mer residents.

151 nostic algorithms that incorporate molecular disease markers, which complement histological impressio

152 rived hNPCs in mice as a tool for monitoring disease markers with EVs.

153 s providing molecular contrast of endogenous disease markers with subcellular spatial resolution have

154 rception abnormalities might act as an early disease marker, with the graphical tool showing potentia

155 may lead to greater insights on subclinical disease markers without apriori assumptions of causality

156 proteins within single biological cells for disease markers without performing polymerase chain reac

157 treatments have appeared promising based on disease markers, yet caused harm when tested in studies